Company completes over-the-counter healthcare business acquisition
Proctor & Gamble Company (Proctor & Gamble) in fiscal 2019 completed the acquisition of the over-the-counter (OTC) healthcare business Merck KGaA (Merck OTC) for $3.7 billion. Merck OTC primarily sells OTC consumer healthcare products across Europe, Latin America and Asia. After the acquisition, Merck OTC is included in Proctor & Gamble’s personal health category. Moreover, in the same fiscal year the company dissolved its PGT Healthcare partnership, a project with Teva Pharmaceutical Industries, Ltd (Teva) in the OTC consumer healthcare business.
Labor|New Activity|M&AIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.